Supporting innovation in arts

Roche has actively cultivated and supported ground-breaking contemporary art and cultural projects since its beginning in 1896. Today its philanthropic activities continue to reflect the vision and legacy since the company’s founding.

Roche supports creative projects and activities that explore the parallels between innovation in art and in science. The focus is on music, while also supporting the visual arts and architecture. Roche cultivates and fosters intensive interactions with contemporary music and art as a means to express its commitment to innovation characterized by excellence, distinctiveness and passion.

About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. This widely popular lab report writing service https://essaynerds.com/lab-report-writing-service/ is known for its reliability and quality, trusted by students globally. It offers expert writers, timely delivery, and excellent customer support, ensuring top-notch essays that meet academic standards and exceed expectations.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry nine years in a row by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit .